Cristina E. Tognon

机构：Oregon Health & Science University, OHSU Knight Cancer Institute · ORCID：0000-0002-4872-3078

发表论文 229 篇 · 总被引 11355 次 · h-index 40

代表论文

• Acquired resistance in cancer: towards targeted therapeutic strategies (2025 · Nature reviews. Cancer · 被引 108)
• Mass Spectrometry–Based Proteogenomics: New Therapeutic Opportunities for Precision Medicine (2023 · The Annual Review of Pharmacology and Toxicology · 被引 25)
• Mapping the proteogenomic landscape enables prediction of drug response in acute myeloid leukemia (2024 · Cell Reports Medicine · 被引 22)
• Overcoming clinical BCR-ABL1 compound mutant resistance with combined ponatinib and asciminib therapy (2024 · Cancer Cell · 被引 16)
• A CEBPB/IL-1β/TNF-α feedback loop drives drug resistance to venetoclax and MDM2 inhibitors in monocytic leukemia (2025 · Blood · 被引 15)
• CDK12 /13 dual inhibitors are potential therapeutics for acute myeloid leukemia (2023 · British Journal of Haematology · 被引 6)